The Enterprise Value as of December 2025 (TTM) for Carmell Therapeutics Corporation (CTCX) is 236.44K

According to Carmell Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 236.44K. This represents a change of -99.69% compared to the average of 76.46M of the last 4 quarters.

Carmell Therapeutics Corporation (CTCX) Historical Enterprise Value (quarterly & annually)

How has CTCX Enterprise Value performed in the past?

The mean historical Enterprise Value of Carmell Therapeutics Corporation over the last ten years is 3.54B. The current 236.44K Enterprise Value has changed -99.33% with respect to the historical average. Over the past ten years (40 quarters), CTCX's Enterprise Value was at its highest in in the June 2023 quarter at 6.11B. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.

Carmell Therapeutics Corporation (CTCX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Carmell Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Carmell Therapeutics Corporation (CTCX) Average Enterprise Value

How has CTCX Enterprise Value performed in the past?

The current Enterprise Value of Carmell Therapeutics Corporation (CTCX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Carmell Therapeutics Corporation (CTCX) Enterprise Value vs. Peers

How is CTCX’s Enterprise Value compared to its peers?

Carmell Therapeutics Corporation’s Enterprise Value is less than Tricida, Inc. (126.38M), less than Entero Therapeutics, Inc. (9.58M), less than Tectonic Therapeutic, Inc. (103.39M), greater than Fresh Tracks Therapeutics, Inc. (-5282955.00), greater than Xenetic Biosciences, Inc. (-359031.00), greater than Neuphoria Therapeutics Inc. (-5981497.00), less than BiondVax Pharmaceuticals Ltd. (23.41M), less than Kineta, Inc. (7.37M), greater than Nabriva Therapeutics plc (-7192677.00), less than ModivCare Inc. (1.29B),

Build a custom stock screener for Carmell Therapeutics Corporation (CTCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carmell Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carmell Therapeutics Corporation (CTCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carmell Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.